Research Education Sport Leisure and Travel

Have you got a story or article?

Click Here

Newsletter Subscription

Sign up for E-mail News

Featured Articles

Billy Caldwell first person to get cannabis on the NHS – Daily Mail Online

Could THIS lead to a cure for multiple sclerosis? Scientists uncover the possible cause of the disease which has long been deemed a mystery

Speed Of Sight Charity 2016 Showcase

The Duke And Duchess Of Cambridge And Prince Harry Show ‘it’s Ok To Say’ In Latest Film For Heads Together Series – DisabledGo Blog

China care centre workers caught beating disabled toddlers – Daily Mail Online

Simtee Few left bedbound after catching Lyme disease – Daily Mail Online

Scientists have discovered the potential cause of MS – Daily Mail Online

How to live the life you want and be a kick-ass disabled person – Disability Horizons

Tennant and Colman support selfie mental health campaign – BBC News

Shops agree to limit sugary drinks sales in hospitals – BBC News

Experts excited by brain ‘wonder-drug’ – BBC News

MS Trust funding new nurses to help more people understand and take on MS this MS awareness week – DisabledGo Blog

Wheelchair User Lenin Moreno Elected President of Ecuador – New Mobility

Mayo Clinic Epidural Stimulation Trial Enables Movement and Stepping – New Mobility

Invisible disability: coping when everyone thinks you’re healthy – Disability Horizons

Ataxia

September 25, is International Ataxia Awareness Day. Chances are you won’t have […]

The selective degeneration of certain neurons in patients with Friedreich’s ataxia may […]

A case report suggests that Friedreich’s ataxia can manifest as abnormal voluntary […]

This report provides comprehensive information on the therapeutic development for Friedreich Ataxia, […]

The Illinois Biotechnology Industry Organization (iBIO) recently announced that Kyle Bryant, founder […]

RaNA Therapeutics, a Cambridge, Massachusetts-based biotech company that develops next-generation RNA-targeted medicines […]

Recently, mutations in transmembrane protein 240 (TMEM240) were identified as the cause […]

Chondrial Therapeutics recently announced that further development of its lead drug candidate […]

Avalanche Biotechnologies, based in Menlo Park, California, is a gene therapy company […]

CAT-4001 is being developed by Catabasis as a potential treatment for neurodegenerative […]